Select Page

Double Marker Test: Uses, Preparation, Procedure, and Results

What is a Double Marker Test?

A Double Marker Test is a prenatal blood test performed during the first trimester of pregnancy to assess the risk of certain chromosomal conditions in the developing baby. The test measures two substances in the mother’s blood: free beta-human chorionic gonadotropin (free ß-hCG) and pregnancy associated plasma protein-A (PAPPA-A). The results are usually assessed along with the mother’s age and ultrasound findings, particularly the nuchal translucency (NT) measurement, to estimate the likelihood of chromosomal conditions such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and, in some screening approaches, Patau syndrome (Trisomy 13). The Double Marker Test is a screening test and does not confirm whether the baby has a chromosomal condition. If the screening indicates an increased risk, the doctor may recommend further evaluation or diagnostic testing.

 

 

double-marker

What Are the Uses of a Double Marker Test?

  • The Double Marker Test is used to estimate the risk of certain chromosomal conditions during early pregnancy.
  • The test helps to assess the likelihood of conditions such as Down syndrome and Edwards syndrome.
  • It is commonly combined with first-trimester ultrasound findings to provide a more comprehensive risk assessment.
  • The test can help doctors determine whether additional prenatal screening or diagnostic testing may be needed.
  • It also provides useful information for counselling and planning further pregnancy care.

When Should You Get a Double Marker Test?

  • A pregnant woman may be advised to undergo the test as part of routine first-trimester prenatal screening.
  • It may be recommended when the doctor wants to assess the baby’s risk of chromosomal abnormalities.
  • The test may be suggested along with an NT scan or other first-trimester screening assessments.
  • It may also be considered when maternal age, medical history, previous pregnancy history, or other factors indicate a need for additional prenatal screening.
  • The doctor may recommend further testing if the Double Marker Test shows a higher than expected risk.

How to Prepare for a Double Marker Test?

  • The Double Marker Test generally does not require fasting or any special dietary preparation. The patient can usually eat and drink normally unless the doctor provides different instructions.
  • The patient should inform the doctor about the pregnancy details, including the gestational age, multiple pregnancy, and any relevant medical or pregnancy history.
  • The test is performed during a specific period of early pregnancy, so the timing should be confirmed with the doctor, particularly when it is being performed along with an NT scan.
  • The patient should carry relevant ultrasound reports and previous pregnancy or medical records if available, as these may be required for accurate risk assessment.

What is the Procedure for a Double Marker Test?

The Double Marker Test begins with cleaning the blood collection area, usually on the arm, using an antiseptic solution. A healthcare professional then collects a small blood sample from a vein using a sterile needle.The blood sample is sent to the laboratory to measure the levels of free ß-hCG and PAPPA-G.The test results may be combined with information such as maternal age, gestational age, and NT scan findings to calculate the estimated risk of chromosomal conditions. The blood collection procedure generally takes only a few minutes.

What Can Affect Double Marker Test Results?

  • The gestational age at the time of testing can influence the levels of the substances measured in the test.
  • Maternal age is an important factor considered while calculating the estimated risk.
  • Multiple pregnancies such as twins or triplets, can affect the levels of the measured markers and the interpretation of results.
  • Maternal weight and certain pregnancy-related factors may also influence the screening calculation.
  • Ultrasound findings, particularly the NT measurement, may be considered along with the blood test results.
  • The results should be interpreted using the laboratory’s reference values and the clinical information provided by the doctor.

Components of Double Marker Test

  • Free Beta-hCG Test: This measures the level of free beta-human chorionic gonadotropin (free β-hCG), a pregnancy-related hormone produced by the placenta.
  • PAPP-A Test: This measures pregnancy-associated plasma protein-A (PAPP-A), a protein produced by the placenta during pregnancy.
  • The levels of both markers are assessed together with other factors to estimate the risk of certain chromosomal conditions.

Understanding Of Double Marker Test Results

A low-risk result means that the screening assessment estimates a lower likelihood of the chromosomal conditions included in the test. However, it does not completely rule out these conditions.

A high-risk or screen-positive result means that the estimated risk is higher than the specified screening threshold. It does not confirm that the baby has a chromosomal abnormality.

If the result indicates an increased risk, the doctor may recommend further evaluation, which may include non-invasive prenatal testing (NIPT), detailed ultrasound assessment, or diagnostic tests such as chorionic villus sampling (CVS) or amniocentesis, depending on the pregnancy and clinical situation.

Double Marker Test results should always be interpreted by a qualified healthcare professional along with ultrasound findings, gestational age, maternal factors, and other relevant clinical information.

Side Effects Of Double Marker Test

The Double Marker Test involves routine blood collection and is generally considered safe for the mother and pregnancy.The patient may experience mild pain or discomfort at the blood collection site.Minor bruising, tenderness, or slight swelling may occur after the blood sample is taken.Some patients may experience temporary dizziness or light-headedness during or after blood collection.Most side effects are mild and usually resolve on their own within a short period.

Need Any Medical Help?

Talk to Our Health Care Experts!

doctor avatar

Need Any Medical Help?

Have any Questions?

Why Choose Yashoda Hospitals

Yashoda Hospitals is committed to providing world-class treatment for patients from across the globe. With the unique combination of state-of-the-art technology, intuitive care, and clinical excellence, we are the healthcare destination for thousands of international patients in India.

blank
Comprehensive Care

On the journey to good health, we understand that it is important for you to feel at home. We plan out all aspects of your trip.

blank
Expert Doctors

Experienced specialists perform non-invasive and minimally invasive surgeries to provide the best treatment for international patients.

blank
Cutting-Edge Technology

Our hospitals are equipped with advanced technology to perform a wide range of procedures and treatments.

blank
Clinical Excellence

We deliver excellence by delivering quick and efficient healthcare and through pioneering research that helps all our future.patients.

References

    1. Liteanu, Andreea & Mihhùan, Marius & Artenie, Vlad. (2010). The importance of the double test in the identification of high-risk pregnancies for chromosomal diseases development. https://www.researchgate.net/publication/265533702_The_importance_of_the_double_test_in_identification_of_high_risk_pregnancies_for_chromosomal_diseases_development
    2. Abdel Dayem, Tamer & El-agwany, Ahmed & Soliman, Tarek & Kholief, Ali & El-Sawy, Mohammed. (2015). Double marker test and uterine Doppler in cases with hyperemesis gravidarum. Evidence-Based Womenʼs Health Journal. 5. 134-139. 10.1097/01.EBX.0000466751.03382.4a. https://www.researchgate.net/publication/281352102_Double_marker_test_and_uterine_Doppler_in_cases_with_hyperemesis_gravidarum

Frequently Asked Questions

The Double Marker Test is a first-trimester prenatal blood test that measures free β-hCG and PAPP-A to estimate the risk of certain chromosomal conditions in the developing baby.

The test is performed to assess the risk of chromosomal conditions such as Down syndrome and Edwards syndrome during early pregnancy. It helps doctors decide whether further screening or diagnostic evaluation may be required.

The Double Marker Test is generally performed during the first trimester, usually along with the NT scan. The exact timing is determined by the gestational age and the doctor's recommendation.

No. Fasting is generally not required for the Double Marker Test. The patient can usually eat and drink normally unless specific instructions are provided by the doctor.

The test measures two pregnancy-related substances in the mother's blood: free beta-hCG and pregnancy-associated plasma protein-A (PAPP-A).

No. The Double Marker Test is a screening test and does not confirm whether the baby has a chromosomal condition. A higher-risk result may require further screening or diagnostic testing.

A high-risk result means that the screening calculation shows an increased likelihood of a particular chromosomal condition. It does not necessarily mean that the baby has the condition. The doctor may recommend additional testing for a clearer assessment.

A low-risk result indicates that the estimated likelihood of the screened chromosomal conditions is lower. However, no screening test can completely eliminate the possibility of a chromosomal condition.

Yes, Double Marker screening may be performed in twin or multiple pregnancies, but the interpretation of the results can be different. The doctor will determine the appropriate screening approach based on the type of pregnancy and clinical requirements.

Yes. The Double Marker Test requires only a blood sample from the mother and does not involve inserting a needle into the uterus or directly accessing the baby. It is therefore considered a non-invasive prenatal screening test.

If the screening result shows an increased risk, the doctor will discuss the result with the patient and may recommend additional screening or diagnostic testing. Further testing helps provide more definitive information about the baby's health.
Book an appointment
in 2 minutes